1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Vantia Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) Fedovapagon 2 mg, Placebo - Nocturia | Phase 2 / Phase 3 | Completed | Vantia Ltd | 432 | 2016-03-01 | 2018-10-31 |
Nocturia (1) · Prostatic Hyperplasia (1)
United States (1)